Cargando…
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populatio...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355991/ https://www.ncbi.nlm.nih.gov/pubmed/35931783 http://dx.doi.org/10.1038/s41531-022-00367-y |
_version_ | 1784763418319781888 |
---|---|
author | Tezuka, Toshiki Taniguchi, Daisuke Sano, Mariko Shimada, Tomoyo Oji, Yutaka Tsunemi, Taiji Ikeda, Aya Li, Yuanzhe Yoshino, Hiroyo Ogata, Jun Shiba-Fukushima, Kahori Funayama, Manabu Nishioka, Kenya Imai, Yuzuru Hattori, Nobutaka |
author_facet | Tezuka, Toshiki Taniguchi, Daisuke Sano, Mariko Shimada, Tomoyo Oji, Yutaka Tsunemi, Taiji Ikeda, Aya Li, Yuanzhe Yoshino, Hiroyo Ogata, Jun Shiba-Fukushima, Kahori Funayama, Manabu Nishioka, Kenya Imai, Yuzuru Hattori, Nobutaka |
author_sort | Tezuka, Toshiki |
collection | PubMed |
description | Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology. |
format | Online Article Text |
id | pubmed-9355991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93559912022-08-07 Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease Tezuka, Toshiki Taniguchi, Daisuke Sano, Mariko Shimada, Tomoyo Oji, Yutaka Tsunemi, Taiji Ikeda, Aya Li, Yuanzhe Yoshino, Hiroyo Ogata, Jun Shiba-Fukushima, Kahori Funayama, Manabu Nishioka, Kenya Imai, Yuzuru Hattori, Nobutaka NPJ Parkinsons Dis Case Report Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology. Nature Publishing Group UK 2022-08-05 /pmc/articles/PMC9355991/ /pubmed/35931783 http://dx.doi.org/10.1038/s41531-022-00367-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Case Report Tezuka, Toshiki Taniguchi, Daisuke Sano, Mariko Shimada, Tomoyo Oji, Yutaka Tsunemi, Taiji Ikeda, Aya Li, Yuanzhe Yoshino, Hiroyo Ogata, Jun Shiba-Fukushima, Kahori Funayama, Manabu Nishioka, Kenya Imai, Yuzuru Hattori, Nobutaka Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease |
title | Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease |
title_full | Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease |
title_fullStr | Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease |
title_full_unstemmed | Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease |
title_short | Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease |
title_sort | pathophysiological evaluation of the lrrk2 g2385r risk variant for parkinson’s disease |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355991/ https://www.ncbi.nlm.nih.gov/pubmed/35931783 http://dx.doi.org/10.1038/s41531-022-00367-y |
work_keys_str_mv | AT tezukatoshiki pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT taniguchidaisuke pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT sanomariko pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT shimadatomoyo pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT ojiyutaka pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT tsunemitaiji pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT ikedaaya pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT liyuanzhe pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT yoshinohiroyo pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT ogatajun pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT shibafukushimakahori pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT funayamamanabu pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT nishiokakenya pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT imaiyuzuru pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease AT hattorinobutaka pathophysiologicalevaluationofthelrrk2g2385rriskvariantforparkinsonsdisease |